Back to search

University of Patras

Μελέτη της επίδρασης των θεραπειών έναντι των ιδιοπαθών φλεγμονωδών νοσημάτων του εντέρου στην ακεραιότητα του βλεννογονικού φραγμού

Abstract

dc:description

Background: Intestinal barrier dysfunction is a hallmark of inflammatory bowel disease (IBD), yet the clinical significance of tight junction (TJ) remodeling remains incompletely understood. In particular, limited information is available regarding the differential involvement of the surface and crypt epithelial compartments and the potential importance of subcellular redistribution of TJ proteins. This study investigated the expression and localization of occludin and claudin-1 in IBD and examined their associations with disease activity, long-term clinical outcomes, and longitudinal changes in relation to treatment.Methods: This retrospective, single-center, real-world study included 220 patients with IBD—100 with Crohn’s disease (CD) and 120 with ulcerative colitis (UC)—and 80 healthy controls. Expression of occludin and claudin-1 was assessed by immunohistochemistry and evaluated separately in the surface epithelium (SE) and crypt epithelium (CR). Protein expression was quantified using the histoscore (H-score), while subcellular localization was classified as regular or irregular. Regular staining was defined as continuous membranous localization, whereas an irregular staining pattern was characterized by cytoplasmic redistribution with reduced or discontinuous membranous staining. Associations with clinical, endoscopic, histological, and laboratory indices were examined. The primary endpoint was IBD-related hospitalization, while secondary endpoints included IBD-related surgery, initiation of biologic therapy, and clinical relapse. Logistic regression and Cox proportional hazards models were used to evaluate clinical outcomes. Longitudinal changes were assessed in 127 patients with available baseline and follow-up biopsies.Results: Both occludin and claudin-1 were dysregulated in active IBD, with increased expression and greater cytoplasmic redistribution compared with remission and healthy controls. These changes were more pronounced in the crypt epithelium. Among the TJ parameters assessed, crypt occludin showed the strongest and most consistent associations with clinical, endoscopic, histological, and inflammatory measures of disease activity. In CD, higher occludin CR expression was independently associated with IBD-related hospitalization (aOR=1.010 per H-score unit; p=0.050) and surgery (aHR=1.013 per H-score unit; p=0.005), whereas an irregular occludin CR staining pattern identified patients more likely to subsequently initiate biologic therapy (aOR=3.48; p=0.030). In UC, both increased occludin CR expression and irregular CR staining were independently associated with IBD-related hospitalization (aOR=1.014; p=0.035 and aOR=2.78; p=0.032, respectively). Higher occludin CR expression was also linked to an increased risk of UC relapse (aHR=1.012; p=0.002). Longitudinal analysis of paired biopsies showed an overall improvement in TJ architecture over time. Occludin expression decreased in the crypt epithelium in both CD and UC, while claudin-1 expression also declined, particularly in UC. These quantitative changes were accompanied by a shift from irregular cytoplasmic localization toward a more regular membranous staining pattern. Changes were most evident in the crypt compartment and were more pronounced among patients exposed to biologic therapy. In exploratory analyses, changes in TJ protein expression were not associated with corresponding changes in conventional disease activity indices, suggesting that epithelial barrier remodeling may reflect a distinct aspect of treatment response.Conclusions: Tight junction remodeling, particularly increased expression and cytoplasmic redistribution of occludin within the crypt epithelium, was associated with disease activity and adverse clinical outcomes in IBD. Longitudinal improvement in crypt TJ architecture further supports its potential value as a tissue-based marker of epithelial recovery and treatment response. Compartment-specific assessment of TJ organization may therefore provide clinically relevant information beyond conventional measures of disease activity.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsounis, Efthymios
  • Τσούνης, Ευθύμιος

Subjects

dc:subject × 28

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/63044

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsounis, Efthymios; Τσούνης, Ευθύμιος. Μελέτη της επίδρασης των θεραπειών έναντι των ιδιοπαθών φλεγμονωδών νοσημάτων του εντέρου στην ακεραιότητα του βλεννογονικού φραγμού. University of Patras, 2026. http://hdl.handle.net/10442/hedi/63044